TS Financial Group (TSFG)’s Vertex Pharmaceuticals VRTX Stock Holding History

TS Financial Group (TSFG)’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$75K	Buy	151 +44	+41%	+$19.5K	0.01%	314
2026 Q1	$48K	Buy	+107	New	+$49.9K	0.01%	352
2024 Q1	–	Sell	-12	Closed	-$5K	–	928
2023 Q4	$5K	Hold	12	–	–	﹤0.01%	615
2023 Q3	$4K	Hold	12	–	–	﹤0.01%	723
2023 Q2	$4K	Buy	12 +2	+20%	+$674	﹤0.01%	718
2023 Q1	$3K	Hold	10	–	–	﹤0.01%	776
2022 Q4	$3K	Hold	10	–	–	﹤0.01%	770
2022 Q3	$3K	Hold	10	–	–	﹤0.01%	738
2022 Q2	$3K	Hold	10	–	–	﹤0.01%	749
2022 Q1	$3K	Hold	10	–	–	﹤0.01%	744
2021 Q4	$2K	Hold	10	–	–	﹤0.01%	790
2021 Q3	$2K	Hold	10	–	–	﹤0.01%	772
2021 Q2	$2K	Hold	10	–	–	﹤0.01%	767
2021 Q1	$2K	Hold	10	–	–	﹤0.01%	694
2020 Q4	$2K	Hold	10	–	–	﹤0.01%	776
2020 Q3	$3K	Hold	10	–	–	﹤0.01%	621
2020 Q2	$3K	Hold	10	–	–	﹤0.01%	607
2020 Q1	$2K	Hold	10	–	–	﹤0.01%	617
2019 Q4	$2K	Hold	10	–	–	﹤0.01%	656
2019 Q3	$2K	Hold	10	–	–	﹤0.01%	670
2019 Q2	$2K	Hold	10	–	–	﹤0.01%	648
2019 Q1	$2K	Buy	+10	New	+$1.85K	﹤0.01%	618

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

TS Financial Group (TSFG)'s VRTX Position: Q2 2026 in Review

TS Financial Group (TSFG) increased its Vertex Pharmaceuticals (VRTX) stake by 41% in Q2 2026, buying an estimated $19.5K and bringing the position to 151 shares worth $75K. The position accounts for 0.01% of the portfolio, ranked #314.

TS Financial Group (TSFG) first reported a position in VRTX in Q1 2019 and has held it in 22 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

TS Financial Group (TSFG) held 151 shares of Vertex Pharmaceuticals worth $75K as of Q2 2026.
TS Financial Group (TSFG) bought 44 Vertex Pharmaceuticals shares in Q2 2026, an estimated $19.5K.
Vertex Pharmaceuticals made up 0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #314 holding.
TS Financial Group (TSFG) first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 22 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.